June 17 (Reuters) - Concordia Healthcare Corp CXR.TO :
* Concordia Healthcare announces PDT with Photofrin data and
provides corporate update
* Concordia Healthcare Corp says positive findings from an
analysis of photodynamic therapy
* Has settled a previously disclosed arbitration proceeding
commenced by a former financial advisor to company
* Concordia Healthcare Corp says also evaluating Photofrin
as a rare disease product candidate through a phase 3 clinical
trial
* As part of settlement, parties have released all claims
against each other; co agreed to pay settlement amount of $12.5
million
* Concordia Healthcare announces PDT with Photofrin data and
provides corporate update
Source text for Eikon: ID:nCNWWv4c3a
Further company coverage: CXR.TO